# A Phase 2 Trial for Patients With Metastatic Solid Cancer

> **NCT04713371** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Rampart Health, L.L.C.** · enrollment: 32 (estimated)

## Conditions studied

- Metastatic Cancer

## Interventions

- **DRUG:** Keytruda Injectable Product
- **DRUG:** Yervoy Injectable Product
- **DRUG:** Cytoxan
- **PROCEDURE:** Cryosurgical freezing (cryosurgery)
- **DRUG:** GM-CSF Injectable

## Key facts

- **NCT ID:** NCT04713371
- **Lead sponsor:** Rampart Health, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-05-19
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2024-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04713371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04713371, "A Phase 2 Trial for Patients With Metastatic Solid Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04713371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*